New Insights into the Genetics of Depression

February 4, 2019 By 23andMe under 23andMe Research   In the largest genetic study of its kind, scientists have identified more than 200 genes associated with depression that could give new insights to researchers looking for treatments to what is the leading cause of disability in the world.     Combining anonymous data from more than two million people who […]

Read More →

Diversity Matters in Research

By 23andMe on Fri, 01 Feb 2019 17:49:06 Africans and African Americans are among the most underrepresented populations in genetic health research, yet they face some of the most daunting health outcomes.   It’s a bitter irony of the current state of research that among those most in need are the least served by our ever-expanding genetic knowledge. Africans, African Americans, as well as Latinos, still make up less than four percent of individuals included in genome-wide association studies, according to a recent study. Genetic Diversity This despite the fact that Africans and people of African ancestry are more genetically diverse than all other populations in the world combined. This is because humans originated in Africa and have lived there continuously for more than 200,000 years, adapting to the varied climates and regions. The rest of the world was populated by small groups of people who first migrated out of Africa some 60,000 to 130,000 years ago. In genetics this is called the Founder Effect. Including people of African ancestry in genetic study will likely uncover unique genetic variation that help scientists better understand conditions that affect people of African ancestry, who thus far have not benefited from many of the breakthroughs in genetic science. Yielding Results 23andMe’s efforts to improve diversity in its research has yielded results. The most promising is that we now have one of the largest groups, if not the largest, group of African Americans who […]

Read More →

23andMe Receives FDA Clearance for Genetic Health Risk report that looks at a Hereditary Colorectal Cancer Syndrome

  By 23andMe on Tue, 22 Jan 2019 17:03:37   23andMe received FDA clearance to report on the two most common genetic variants influencing what is called MUTYH-associated polyposis (MAP), a hereditary colorectal cancer syndrome.This new clearance is part of… The post 23andMe Receives FDA Clearance for Genetic Health Risk report that looks at a Hereditary Colorectal Cancer Syndrome appeared first on 23andMe Blog.

Read More →